MOM Share Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month 0.00 0.00
Volume 136000 1 Year -0.01 -50.00
52 Week High 0.03
52 Week Low 0.01
MOM Important Levels
Resistance 2 0.01
Resistance 1 0.01
Pivot 0.01
Support 1 0.01
Support 2 0.01
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
CBE 0.02 100.00%
CBE 0.02 100.00%
CBE 0.02 100.00%
NUK 0.02 100.00%
BVQ 0.02 100.00%
DDX 0.50 100.00%
DYG 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
RDM 0.21 90.91%
More..
CVE Canada Top Losers Stocks
ARH 0.00 -100.00%
ARH 0.00 -100.00%
MLR 0.02 -50.00%
MLR 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Miraculins Inc. (CVE: MOM)

MOM Technical Analysis 5
As on 13th Apr 2016 MOM Share Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.05 & Strong Sell for SHORT-TERM with Stoploss of 0.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
MOM Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
MOM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.miraculins.com
MOM Address
MOM
6-1250 Waverley Street
Winnipeg, MB R3T 6C6
Canada
Phone: 204-453-1408
Fax: 204-453-1546
Interactive Technical Analysis Chart Miraculins Inc. ( MOM CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Miraculins Inc.
MOM Business Profile
Miraculins Inc., a medical diagnostic company, focuses on acquiring, development, and commercialization of non-invasive technologies for unmet clinical needs in Canada. The company's PreVu non-invasive skin cholesterol test, a coronary artery disease risk assessment technology that measures cholesterol levels in a patient's skin; and SCOUT DS system, a non-invasive diabetes screening system designed to provide sensitive and convenient method for screening for pre-diabetes and type 2 diabetes based on the presence of diabetes-related biomarkers found in skin. It also develops preeclampsia diagnostic test for preeclampsia, a pregnancy specific disease; and offers testing services. The company was incorporated in 1998 and is headquartered in Winnipeg, Canada.